Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAlbayrak, Yakup
dc.contributor.authorÜnsal, Cüneyt
dc.contributor.authorBeyazyüz, Murat
dc.contributor.authorÜnal, Ahmet
dc.contributor.authorKuloğlu, Murat
dc.date.accessioned2022-05-11T14:41:04Z
dc.date.available2022-05-11T14:41:04Z
dc.date.issued2013
dc.identifier.issn0278-5846
dc.identifier.issn1878-4216
dc.identifier.urihttps://doi.org/10.1016/j.pnpbp.2013.04.020
dc.identifier.urihttps://hdl.handle.net/20.500.11776/9047
dc.description.abstractIntroduction: Deficit schizophrenia (DS) is defined for identifying a relatively homogeneous subgroup of patients with diagnosis of schizophrenia, characterized by the presence of primary and enduring negative symptoms. There have been several studies which investigated the status of oxidative stress and total antioxidant level in patients with schizophrenia. However, there is not any study which researched differences between DS and nondeficit schizophrenia (NDS) in terms of status of oxidative stress and antioxidant level. We hypothesized that patients with DS would have different status of oxidative stress and antioxidant levels compared with patients with NDS. Methods: Twenty-three patients with DS, 42 patients with NDS and 31 age, sex and smoking status matched healthy controls (HC) were included to study. Five milliliters of blood was drawn from control subjects and patients for assessing total antioxidant potential (TAOP) and total peroxide levels (TPEROX). The ratio of TPEROX to TAOP is referred as oxidative stress index (OSI). Results: We noticed that serum TAOP level was significantly lower in DS group compared with NDS and HC groups. The OSI was also found to be higher in DS group compared with NDS and HC groups. Furthermore, serum TAOP level and status of OSI were similar between NDS and HC groups. Conclusion: Our study is the first to demonstrate differences between DS and NDS in terms of status of oxidative stress and serum total antioxidant level. We suggest that our study represents novel and important results in terms of supporting provides and hypothesis which considered DS as a different disease entity with respect to NDS. Further studies are needed for investigating the status of antioxidants and oxidative stress and their clinical implications in deficit schizophrenia. (C) 2013 Elsevier Inc. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.identifier.doi10.1016/j.pnpbp.2013.04.020
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntioxidanten_US
dc.subjectDeficit schizophreniaen_US
dc.subjectOxidative stressen_US
dc.subjectPlacebo-Controlled Trialen_US
dc.subjectLipid-Peroxidationen_US
dc.subjectSuperoxide-Dismutaseen_US
dc.subjectGinkgo-Bilobaen_US
dc.subjectEnzyme Levelsen_US
dc.subjectDefense Systemen_US
dc.subjectFatty-Acidsen_US
dc.subjectVitamin-Een_US
dc.subjectHaloperidolen_US
dc.subjectBrainen_US
dc.titleReduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary studyen_US
dc.typearticleen_US
dc.relation.ispartofProgress in Neuro-Psychopharmacology & Biological Psychiatryen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Ruh Sağlığı ve Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0002-8612-528X
dc.authorid0000-0002-5770-344X
dc.identifier.volume45en_US
dc.identifier.startpage144en_US
dc.identifier.endpage149en_US
dc.institutionauthorÜnsal, Cüneyt
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid29067508300
dc.authorscopusid26432848600
dc.authorscopusid27967486000
dc.authorscopusid55416074700
dc.authorscopusid55891056300
dc.authorwosidBEYAZYUZ, MURAT/ABA-7934-2020
dc.authorwosidÜnal, Ahmet/ABH-9455-2020
dc.authorwosidAlbayrak, Yakup/ABA-7651-2020
dc.identifier.wosWOS:000323238300019en_US
dc.identifier.scopus2-s2.0-84878851248en_US
dc.identifier.pmid23657077en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster